Entrada Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
TRDA on Nasdaq
Industry
Pharmaceutical Preparations
Location
One Design Center Place, Suite 17 500, Boston, MA

Insiders trading volume in the past year

Entrada Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
MPM BioVentures 2014, L.P. 10%+ Owner $88.6M -$917K -1.02% Dec 10, 2024
Mpm Bioventures 2018, L.P. 10%+ Owner $88.6M -$917K -1.02% Dec 10, 2024
Todd Foley Director, 10%+ Owner $70.8M Jun 2, 2022
Roche Holding Ltd 10%+ Owner $45M Nov 2, 2021
Baker Bros. Advisors Lp 10%+ Owner $37.1M +$1.35M +3.78% Nov 10, 2025
5AM Ventures V, L.P. 10%+ Owner $32.8M -$2.83M -7.93% Nov 14, 2025
Kush Parmar Director, 10%+ Owner $32.8M -$2.83M -7.93% Nov 14, 2025
Redmile Group, LLC 10%+ Owner $31.3M Nov 2, 2021
Dipal Doshi CEO, Director $2.26M Sep 2, 2025
Peter S. Kim Director $1.71M Jun 11, 2025
Natarajan Sethuraman President, Research & Develop. $1.07M -$321K -23% Sep 2, 2025
Nathan J. Dowden President & COO $972K Sep 2, 2025
Kory James Wentworth Chief Financial Officer $646K -$139K -17.7% Sep 2, 2025
Nerissa Kreher Chief Medical Officer $640K Sep 1, 2023
Carole Nuechterlein Director Jun 2, 2022
Gina Chapman Director Jun 11, 2025
Bernhardt G. Zeiher Director Jun 11, 2025
John F. Crowley Director Jun 8, 2023
Mary Thistle Director Jun 11, 2025
Maha Radhakrishnan Director Jun 1, 2025

Recent Insider Transactions by Companies or Individuals for Entrada Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.